Results 11 to 20 of about 13,105 (215)

Thrombocytopenia After Aortic Valve Replacement: Comparison Between Sutureless Perceval S Valve and Perimount Magna Ease Bioprosthesis

Brazilian Journal of Cardiovascular Surgery, 2018
Introduction The incidence of postoperative thrombocytopenia after aortic valve replacement (AVR) with the Perceval S Sutureless bioprosthesis remains unclear. The aim of this study was to report thrombocytopenia associated with the use of sutureless AVR.
S. S. Mujtaba, S. Ledingham, A. Shah, S. Schueler, S. Clark, T. Pillay   +5 more
semanticscholar   +2 more sources

EARLY DEGENERATED BIOPROSTHETIC MITRAL VALVE [PDF]

Romanian Journal of Pediatrics, 2014
Mitral valve prolapse (MVP) is fairly common in children, often being randomly found in asymptomatic, as well as in symptomatic patients with conjunctive tissue diseases (CTD). The authors report the case of an 11-yearold girl, diagnosed at the age of 6
Irina-Mihaela Ciomaga, Georgiana Russu, Cristina Jitareanu, Violeta Streanga, Aniela Rugina, Nicolai Nistor   +5 more
doaj   +1 more source

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease

Frontiers in Cardiovascular Medicine, 2021
Background: Bioprosthetic heart valve has limited durability and lower long-term performance especially in rheumatic heart disease (RHD) patients that are often subject to multiple redo operations.
Mariana Pezzute Lopes, Vitor Emer Egypto Rosa, José Honório Palma, Marcelo Luiz Campos Vieira, Joao Ricardo Cordeiro Fernandes, Antonio de Santis, Guilherme Sobreira Spina, Rafael de Jesus Fonseca, Mauricio F. de Sá Marchi, Alexandre Abizaid, Fábio Sândoli de Brito, Flavio Tarasoutchi, Roney Orismar Sampaio, Henrique Barbosa Ribeiro   +13 more
doaj   +1 more source

Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis.

EuroIntervention, 2021
BACKGROUND Limited data are available regarding clinical outcomes of valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) following the United States Food and Drug Administration approval of ViV TAVI in 2015.
M. Majmundar, R. Doshi, Ashish Kumar, Douglas Johnston, James Brockett, Anmar Kanaa’n, J. Lahorra, L. Svensson, A. Krishnaswamy, G. Reed, R. Puri, S. Kapadia, A. Kalra   +12 more
semanticscholar   +1 more source

Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis

European Journal of Cardio-Thoracic Surgery, 2020
OBJECTIVES Long-term durability of bioprosthetic valves is predominantly limited by structural valve deterioration. RESILIA™ tissue has exhibited reduced calcification in pre-clinical and early clinical studies.
K. Bartus, R. Litwinowicz, A. Bilewska, M. Stąpór, M. Bochenek, J. Różański, J. Sadowski, Grzegorz Filip, M. Kuśmierczyk, B. Kapelak   +9 more
semanticscholar   +1 more source

Is distortion of the bioprosthesis ring a risk factor for early calcification ?

Journal of Cardiothoracic Surgery, 2010
Background As the population ages, bioprosthesis are increasingly being used in cardiac valve replacement. Pericardial bioprosthesis combine an excellent hemodynamic performance with low thrombogenicity, but valve failure associated with calcification ...
de Alegria Anxo, Quiroga Juan, Alvarez Jose, Cereijo Jose, Suarez Peñaranda Jose   +4 more
doaj   +1 more source

The importance of the use of bovine pericardium for surgical reconstructions: a systematic review

Revista Médica de Minas Gerais, 2022
Introduction: The use of bovine pericardium started in 1972 in cardiovascular surgeries. From the evolution of tissue engineering with care in the preparation of the material, minimizing the risk of rejection and facilitating the use for various types
Gomes, Maria Clara Nonato Soares, Cruz, Daniella Gomes, Alberti, Luiz Ronaldo   +2 more
doaj   +1 more source

Pulsed Cavitational Ultrasound Softening

JACC: Basic to Translational Science, 2017
The authors propose a novel noninvasive therapeutic approach for degenerative calcified bioprosthetic heart valves based on pulsed cavitational ultrasound (PCU) to improve the valvular function by remotely softening calcified stiff cusps. This study aims
Olivier Villemain, MD, Justine Robin, MS, Alain Bel, MD, Wojciech Kwiecinski, PhD, Patrick Bruneval, MD, Bastien Arnal, PhD, Mathieu Rémond, PhD, Mickael Tanter, PhD, Emmanuel Messas, MD, PhD, Mathieu Pernot, PhD   +9 more
doaj   +1 more source

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years

Frontiers in Cardiovascular Medicine, 2022
BackgroundRheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people.
Jun Yu, Wei Wang
doaj   +1 more source

Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis

Brazilian Journal of Cardiovascular Surgery, 2015
INTRODUCTION: The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients.
Walter J. Gomes, João Carlos Leal, Fabio Biscegli Jatene, Nelson A. Hossne Jr, Renata Gabaldi, Glaucia Basso Frazzato, Guilherme Agreli, Domingo M. Braile   +7 more
doaj   +1 more source